Hosted on MSN2h
Glenmark Expands Ophthalmic Portfolio in the US with Latanoprost Launch
Inc., USA (Glenmark) has announced the launch of Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), further strengthening ...